Pathstone Holdings’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Buy |
221,852
+7,093
| +3% | +$110K | 0.01% | 703 |
|
|
2025
Q1 | $3.19M | Sell |
214,759
-101,553
| -32% | -$1.51M | 0.01% | 740 |
|
|
2024
Q4 | $4.19M | Sell |
316,312
-114,364
| -27% | -$1.51M | 0.02% | 613 |
|
|
2024
Q3 | $6.12M | Buy |
430,676
+4,280
| +1% | +$60.9K | 0.03% | 485 |
|
|
2024
Q2 | $5.52M | Sell |
426,396
-5,787
| -1% | -$74.9K | 0.02% | 490 |
|
|
2024
Q1 | $6M | Buy |
432,183
+106,237
| +33% | +$1.48M | 0.03% | 450 |
|
|
2023
Q4 | $4.65M | Buy |
+325,946
| New | +$4.65M | 0.03% | 451 |
|